To date, counterregulatory hormone and symptom responses to hypoglycaemia have not been directly compared between people with type 1 diabetes and those with insulin-treated type 2 diabetes vis-à-vis controls without diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.